Secondary Cancer Risk After Radiation Therapy for Rectal Cancer
Condition(s):Neoplasms, Second PrimaryLast Updated:December 13, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Neoplasms, Second PrimaryLast Updated:December 13, 2016Completed
Condition(s):Gastric Tumor; Helicobacter Pylori; Endoscopic Resection; Metachronous NeoplasmsLast Updated:March 14, 2012Completed
Condition(s):Head and Neck Neoplasms; Recurrence; Neoplasms, Second PrimaryLast Updated:June 19, 2013Completed
Condition(s):Ann Arbor Stage IIB Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IVA Hodgkin Lymphoma; Ann Arbor Stage IVB Hodgkin Lymphoma; Childhood Hodgkin Lymphoma; Classic Hodgkin LymphomaLast Updated:December 21, 2023Active, not recruiting
Condition(s):Childhood Cancer; Genetic Predisposition; Late EffectLast Updated:January 13, 2021Recruiting
Condition(s):Stage I-II Head and Neck CancerLast Updated:June 15, 2023Completed
Condition(s):Metachronous Neoplasm; Gastric Cancer; Gastric Neoplasm; Aberrant DNA MethylationLast Updated:April 5, 2021Completed
Condition(s):Breast Cancer; BRCA1 Mutation; BRCA2 Mutation; Recurrent Breast Cancer; Metachronous NeoplasmLast Updated:November 30, 2020Unknown status
Condition(s):Prostatic NeoplasmsLast Updated:January 19, 2018Completed
Condition(s):Breast Neoplasm; Brain Neoplasm; Second NeoplasmLast Updated:June 14, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.